 Fenoldopam
"Fenoldopam" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
| Descriptor ID |
D018818
|
| MeSH Number(s) |
D03.438.079.300
|
| Concept/Terms |
SK&F-82526- SK&F-82526
- SK&F 82526
- SK&F82526
- SKF-82526
- SKF 82526
- SKF82526
SKF-82526J- SKF-82526J
- SKF 82526J
- SKF82526J
- SK&F-82526J
- SK&F 82526J
- SK&F82526J
|
Below are MeSH descriptors whose meaning is more general than "Fenoldopam".
Below are MeSH descriptors whose meaning is more specific than "Fenoldopam".
This graph shows the total number of publications written about "Fenoldopam" by people in this website by year, and whether "Fenoldopam" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1984 | 0 | 2 | 2 | | 1985 | 0 | 3 | 3 | | 1986 | 0 | 2 | 2 | | 1987 | 0 | 3 | 3 | | 1988 | 0 | 1 | 1 | | 1989 | 0 | 1 | 1 | | 1990 | 0 | 2 | 2 | | 1991 | 0 | 1 | 1 | | 1992 | 0 | 1 | 1 | | 1993 | 0 | 1 | 1 | | 1994 | 0 | 2 | 2 | | 1995 | 1 | 1 | 2 | | 1997 | 0 | 1 | 1 | | 1998 | 0 | 1 | 1 | | 2000 | 0 | 2 | 2 | | 2002 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Fenoldopam" by people in Profiles.
-
Stephens CT, Jandhyala BS. Effects of fenoldopam, a dopamine D-1 agonist, and clevidipine, a calcium channel antagonist, in acute renal failure in anesthetized rats. Clin Exp Hypertens. 2002 May; 24(4):301-13.
-
Venkatakrishnan U, Chen C, Lokhandwala MF. The role of intrarenal nitric oxide in the natriuretic response to dopamine-receptor activation. Clin Exp Hypertens. 2000 Apr; 22(3):309-24.
-
Schafer JA, Li L, Sun D. The collecting duct, dopamine and vasopressin-dependent hypertension. Acta Physiol Scand. 2000 Jan; 168(1):239-44.
-
Li L, Schafer JA. Dopamine inhibits vasopressin-dependent cAMP production in the rat cortical collecting duct. Am J Physiol. 1998 Jul; 275(1 Pt 2):F62-7.
-
Hussain T, Lokhandwala MF. Renal dopamine DA1 receptor coupling with G(S) and G(q/11) proteins in spontaneously hypertensive rats. Am J Physiol. 1997 Mar; 272(3 Pt 2):F339-46.
-
Chen C, Lokhandwala MF. Potentiation by enalaprilat of fenoldopam-evoked natriuresis is due to blockade of intrarenal production of angiotensin-II in rats. Naunyn Schmiedebergs Arch Pharmacol. 1995 Aug; 352(2):194-200.
-
Kansra V, Chen C, Lokhandwala MF. Dopamine causes stimulation of protein kinase C in rat renal proximal tubules by activating dopamine D1 receptors. Eur J Pharmacol. 1995 Apr 28; 289(2):391-4.
-
Jacinto SM, Lokhandwala MF, Jandhyala BS. Studies on the pharmacological interventions to prevent oxygen free radical (OFR)-mediated toxicity; effects of dopexamine, a DA1 receptor and beta 2 adrenoceptor agonist. Naunyn Schmiedebergs Arch Pharmacol. 1994 Sep; 350(3):277-83.
-
Jacinto SM, Jandhyala BS. Salutary effects of dopexamine, a DA-1 and beta-2 agonist, on free radical-induced toxicity in anesthetized rats. Ann N Y Acad Sci. 1994 Jun 17; 723:349-52.
-
Chen C, Lokhandwala MF. Inhibition of Na+,K(+)-ATPase in rat renal proximal tubules by dopamine involved DA-1 receptor activation. Naunyn Schmiedebergs Arch Pharmacol. 1993 Mar; 347(3):289-95.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|